Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank67
3Y CAGR-31.8%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-31.8%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$2.04M-67.3%
2024$6.24M+120.6%
2023$2.83M-56.0%
2022$6.42M+334.8%
2021$1.48M-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-